Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is >= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of >= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (>= 180 SBP).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05881252
Study type Observational
Source The University of Texas Health Science Center, Houston
Contact Kristen Cagino, MD
Phone 713-500-6412
Email Kristen.A.Cagino@uth.tmc.edu
Status Recruiting
Phase
Start date May 11, 2023
Completion date June 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05726279 - PROtecting Maternal Brains From Injury and Stroke N/A
Not yet recruiting NCT06344702 - The Effect of CPAP on Maternal and Infant Outcomes in Pregnant Women With OSAS
Recruiting NCT04766866 - sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term. N/A
Recruiting NCT05551104 - Safest Choice of Antihypertensive Regimen for Postpartum Hypertension Phase 3